期刊文献+

非小细胞肺癌术后辅助治疗疗效分析 被引量:3

An analysis of effect postoperative adjuvant therapy for non-small lung cancer
下载PDF
导出
摘要 目的 :分析非小细胞肺癌术后辅助治疗的疗效。方法 :非小细胞肺癌Ⅱ期和Ⅲa期 2 99例分别采用单纯手术、术后放疗、术后放疗 +化疗并用的方法进行治疗。结果 :非小细胞肺癌Ⅱ期和Ⅲa期术后放疗组与术后放疗 +化疗组局部控制率优于单纯手术组 (P <0 0 5 ) ,但远处转移率及 5年生存率无统计学意义。结论 :治疗方法及病理类型并不影响Ⅱ期和Ⅲa期非小细胞肺癌术后生存率 。 Objective:To study the effects of therapy methods on the survival rate for non small cell lung cancer(NSCLC) stage Ⅱ and stageⅢ a after radical operation.Methods:From April 1988 to December 1994,treatment results were compared between 212 stage Ⅱ and 87 stageⅢa NSCLC who received operation alone (OA),postoperation radiotherapy(RT),radiotherapy and chemotherapy (CRT) in our department.Results:The local recurrent rates for stage Ⅱand stageⅢa with RT group and CRT group compared with OA group have significance( P <0.05),but distance metastasis rates and the five survival rates for stage Ⅱ and stage Ⅲa with RT group and CRT group compared with OA group have insignificance ( P >0.05) Conclusions:No relationship was found between the survival rates and pathological classification and treatment method.Radiation may reduce local recurrent rates for postoperation of NSCLC.
作者 付尚志 蒲萍
出处 《临床肿瘤学杂志》 CAS 2002年第1期32-34,共3页 Chinese Clinical Oncology
关键词 非小细胞肺癌 治疗效果 手术治疗 辅助治疗 放射治疗 Non small cell lung cancer After operation Radiotherapy/Chemotherapy Treatment effect/Analysis
  • 相关文献

参考文献7

二级参考文献12

  • 1傅深,蒋国梁,王丽娟,钱浩,叶明,傅晓龙,赵森,何少琴,刘泰福.超分割放疗非小细胞肺癌疗效分析──临床Ⅲ期研究[J].中华肿瘤杂志,1994,16(4):306-309. 被引量:18
  • 2谢大业 蒋国梁 许立功 等.肺癌[A].汤钊猷.现代肿瘤学[C].上海:上海医科大学出版社,1993.626-647.
  • 3Naurkc T,Goya T,Tshuchiya R,et al.The importance of surgery to non-small cell carinoma of lung with mediastinal lymph node metastasis.Ann Thorac Surg,1988,46:603-610.
  • 4Mountain CF,Expanded possibilities for surgical treatment of lung cancer,Survival in stage Ⅲ a disease.Chest,1990,97:1045-1051.
  • 5Branislav J,Yuto S,Ljubisa A,et al.Hyperfractionated radiation therapy with or without concurrent low-dose carboplatin/etopside for non-small cell lung cancer:a randomized study.J Clin Oncol,1996,14:10565-1070.
  • 6Saunders MI,Dische S,Barrett A,et al.Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small cell lung cancer.and interim report.CHART Steering Committee.Br J Cancer,1996,73(12):1455-62.
  • 7Burkees RL,Sheperherd FA,Ginsberg RJ,et al.Induction chemotherapy with MVP in patients with stage Ⅲ a (T1-3 N2M0)unresectable non-small cell lung cancer(NSCLC)The Toronto experience(meeting abstract)Proc Annu Meet.Am Soc Clin Oncol,1994,13 A1078.
  • 8Albalin Ks,Rusch VW,Crowley JJ,et al.Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage Ⅲa(N2)and Ⅲb non-small cell lung cancer mature results of Southwest Oncology Group Phase II Study 8805.J Clin Oncol,1995,13(8):1880-1892.
  • 9Lee JS,Scott C,Komaki R,et al.Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer.Radiation Therapy Oncology Group Protocal 91-06.J Clin Oncol,1996,14(4):1055-1064.
  • 10胡继顺,马中骥,蒋则达,鞠风武.全胸移动条野放射治疗恶性胸水[J].中华放射肿瘤学杂志,1995,4(1):39-40. 被引量:5

共引文献83

同被引文献31

  • 1沈德义,寿伟臻,裴广廷.Ⅲ期(N_2)非小细胞肺癌切除后辅助治疗的探讨[J].实用肿瘤学杂志,1995,9(2):60-60. 被引量:9
  • 2Moher D, Pham B, Jones A, et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in Meta-analysis[ J]. Lancet, 1998,352 : 609-613.
  • 3Nakagawa K, Tada H, Akashi A, et al. Randomised study of adjuvant chemotherapy for completely resected p-stage Ⅰ -ⅢA non- small cell lung cancer[J]. Br J Cancer, 2006, 95:817-821.
  • 4Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage Ⅰ BⅢ A non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ ANITA ] ) : a randomised controlled trial [ J ]. Lancet Oncol, 2006, 7 ( 9 ) :719 -727.
  • 5Munehisa I. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage Ⅰ non-small cell lung cancer [ J ]. Lung Cancer, 2005, 49:85-94.
  • 6Timothy W, Robert L, David J, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer[J]. N Engl J Med, 2005, 352(25) :2589-2597.
  • 7Jong HP, Lee CT, Lee HW, et al. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer[J]. Eur J Cardiothoracic Surg, 2005, 27:1086-1091.
  • 8Nakagawa M, Tanaka F, Tsubota N, et al. A randomized phase Ⅲ trial of adjuvant chemotherapy with UFT for completely resected pathological stage Ⅰ non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)-the 4th study [J]. Ann Oncol, 2005, 16(1) :75-80.
  • 9The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J]. N Engl J Med, 2004, 350(4) :351-360.
  • 10Waller D, Peake R J, Stephens D, et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial[ J ]. Eur J Cardiothorac Surg, 2004,26 : 173-182.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部